Has Hai Xu received payments from drug or device companies?

Yes. Drug and device makers reported $24,975 in general payments to Hai Xu across 128 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hai Xu did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hai Xu come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hai Xu

Interventional Cardiology · Bismarck, NDNPI 1093133878

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $17,487 of the $24,975 with a category attached, or 70.0%. 20 manufacturers reported payments, led by Philips North America LLC at 52.6% of the total. Reporting peaked in 2024 at $18,589 and has fallen 70.9% since, to $5,412 in 2025.

$24,975in general payments, 2019–2025

Across 128 payments — averaging $195.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Philips North America LLC$13K
Abbott$5K
Boston Scientific$4K
Boehringer Ingelheim$388
Abiomed$377
Medtronic$352
plus $1K from 14 others

What the payments were for

Grants$1,0634%
Travel & lodging$17,48770%
Food & beverage$6,42526%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Philips North America LLC	15	$13,135
Abbott	38	$5,227
Boston Scientific	29	$4,279
Boehringer Ingelheim	5	$388
Abiomed	5	$377
Medtronic	6	$352
Stryker	2	$222
Novartis	9	$173
Johnson & Johnson(2 entities)	2	$159
Penumbra, Inc.	1	$141
Inari Medical, Inc.	1	$122
Pfizer	4	$89
E.r. Squibb & Sons, L.L.C.	2	$76
Chiesi USA, Inc.	1	$70
Actelion Pharmaceuticals US, Inc.	2	$42
Irhythm Technologies, Inc.	1	$30
Biotronik Inc.	2	$28
Teleflex LLC	1	$23
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$22
Alnylam Pharmaceuticals Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional cardiology providers in North Dakotato place this figure against a meaningful peer group, so we don't.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BrilintaTicagrelor	12	$11,113
ClopidogrelClopidogrel Bisulfate	11	$142

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Bismarck

Nayan DesaiBismarck$413K
Jared SteinbergerBismarck$9K
Camelia IlieBismarck$1K
John HoytBismarck$1K
Boban MathewBismarck$124
Robert OatfieldBismarck$45
Alok SauravFargo$10K
Yara Letitia CameronGrand Forks$8K
Puneet SharmaFargo$7K
Yassar AlmanaseerFargo$7K

See the full list for North Dakota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →